高联素-35表达与类风湿性部狭窄症的严重程度有关
Ping Wang1, Yaxiong Li2, Li Zhao3
1Department of Cardiovascular Surgery, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, Yunnan, China.
Frontiers in immunology
|April 23, 2025
概括
干白素-35 (IL-35) 水平在风湿性心肌狭窄症 (RMS) 患者中升高,与疾病严重程度相关. 这表明IL-35在RMS进展中起作用.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 风湿性心肌狭窄症 (RMS) 是心脏病发病率和死亡率的重要原因.
- 介素-35 (IL-35) 是一种抗炎性细胞因子,涉及到自身免疫性疾病.
- IL-35在RMS病变发生中的作用以前没有被描述.
研究的目的:
- 为了研究RMS患者的IL-35表达.
- 确定IL-35水平与RMS疾病严重程度之间的关联.
- 探索IL-35在RMS进展中的潜在作用.
主要方法:
- 40名RMS患者 (20名中度,20名重度) 和使用ELISA的20名健康对照的血清中的量化IL-35.
- 通过西部斑块和免疫组织化学评估RMS患者和对照组中中枢 (MV) 组织中的IL-35及其子单位 (p35,EBI3) 表达.
主要成果:
- 在RMS患者和对照人群中,IL-35的血液水平显著更高 (p<0.05) 和与RMS严重程度 (r=0.317,p<0.05) 有正相关.
- 在RMS MV组织中检测到IL-35及其子单位 (p35,EBI3),表达与疾病严重程度积极相关 (r=0.528至0.561,p<0.01).
- 在MV组织中观察到p35和EBI3的同定位,主要是围血管模式.
结论:
- 这项研究首次表明,在RMS患者的血液和MV组织中,IL-35的升高.
- IL-35水平与RMS严重程度有很强的相关性,这表明它在疾病进展中起着调节作用.
- IL-35可能是一个潜在的治疗点,用于管理类风湿性心肌狭窄症.
更多相关视频
08:09Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
8.0K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
352
相关概念视频
T Cell Types and Functions
617
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
617
The JAK-STAT Signaling Pathway
8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.4K
